Pharma
Living with SANDO – a long road to diagnosis
42-year-old Mark shares his story living with Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis (SANDO) disease, a rare mitochondrial condition that affects the brain, muscles, nerves and eyes. He discusses everything from the long road to diagnosis, his brother developing sym...
Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering
BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division. ...
NIHR IMID BioResource recruits its 10,000th volunteer in major milestone
The platform for research into Immune-Mediated Inflammatory Diseases (IMIDs) has now signed up 10,000 participants nationwide. Find out about the value of having such a large cohort and what it means for future research studies into IMIDs. ...
Key human bladder cancer genes pinpointed in cats and dogs
Key bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding which of many mutations are the most important in the cancer’s development. ...
Bio-Rad Launches First StarBright™ Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
With 29 additional targets the range also includes dog, cow, and pig targets to support translational models in veterinary immunology research. ...
The power of contact lenses: drug delivery to the eye and more
Jaynell Ng, Graduate Electronics and Software Engineer, shares her experience living with Myopia and discusses how there is more to contact lenses than meets the eye. ...
Medical affairs evolution
Consultants from CRA’s Life Sciences Practice conducted a survey with n=50 leaders in Medical Affairs to learn from their perspectives on trends and challenges in the industry. When asked which market factors are pushing their team to evolve, respondents ranked patient centricity,...
Outlining the need for early reimbursed access to curative therapies
Early access to curative therapies is vital to support the clinical benefits they can provide to both patients and healthcare systems. Early access programs (EAPs) are a mechanism to facilitate faster patient access to curative therapies. ...
Latest updates from Cresset - August 2023 Newsletter
Welcome to the August Cresset Newsletter Discover this month's latest CADD software news and molecular modeling expertise, all in support of enabling seamless collaboration and enhanced insights across the DMTA cycle. You can subscribe to our monthly newsletter list&nbs...
Lunch & Learn: Clinical Trial Evolution in the EU & CMC Strategy
Join us for the next Lunch & Learn session in collaboration with Scendea!